Skip to main content
. 2018 Jul 17;8:10814. doi: 10.1038/s41598-018-29144-9

Figure 6.

Figure 6

pSPHK1 is overexpressed in biliary tract cancer with lymph node metastasis on immunohistochemistry. (a) Semi-quantitative analysis of the immunohistochemical pSPHK1 expression in gallbladder cancer tissues with (n = 10) or without lymph node metastasis (n = 10) was performed. A staining score was calculated by multiplying two scores of staining intensity (0: negative staining; 1: weak staining; 2: moderate staining; 3: strong staining) and extent (0: 0–25%; 1: 26–50%; 2: 51–75%; 3: 76% -) of biliary tract cancer cells staining positive. The score of 0 to 5 was considered pSPHK1-negative, and 6 to 12 pSPHK1-positive. The score was compared between gallbladder cancer tissues with (n = 10) or without lymph node metastasis (n = 10) using Fisher’s exact test. The test was two-sided, and P value < 0.05 was considered statistically significant. Scale bar = 200 µm. (b) The staining intensity was determined and scored as 0 (negative staining), 1 (weak staining), 2 (moderate staining) and 3 (strong staining). Scale bar = 200 µm. (c) The result of immunohistochemical staining of pSPHK1 for gallbladder cancer with or without lymph node metastasis is shown.